Đang chuẩn bị liên kết để tải về tài liệu:
Báo cáo y học: "Ultrasound guided injection of dexamethasone versus placebo for treatment of plantar fasciitis: protocol for a randomised controlled trial"
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Ultrasound guided injection of dexamethasone versus placebo for treatment of plantar fasciitis: protocol for a randomised controlled trial. | McMillan et al. Journal of Foot and Ankle Research 2010 3 15 http www.jfootankleres.eom content 3 1 15 JOURNAL OF FOOT AND ANKLE RESEARCH STUDY PROTOCOL Open Access Ultrasound guided injection of dexamethasone versus placebo for treatment of plantar fasciitis protocol for a randomised controlled trial Andrew M McMillan 1 2 Karl B Landorf1 2 Mark F Gilheany1 2 Adam R Bird1 2 Adam D Morrow1 2 and Hylton B Menz2 Abstract Background Plantar fasciitis is the most commonly reported cause of chronic pain beneath the heel. Management of this condition commonly involves the use of corticosteroid injection in cases where less invasive treatments have failed. However despite widespread use only two randomised trials have tested the effect of this treatment in comparison to placebo. These trials currently offer the best available evidence by which to guide clinical practice though both were limited by methodological issues such as insufficient statistical power. Therefore the aim of this randomised trial is to compare the effect of ultrasound-guided corticosteroid injection versus placebo for treatment of plantar fasciitis. Methods The trial will be conducted at the La Trobe University Podiatry Clinic and will recruit 80 community-dwelling participants. Diagnostic ultrasound will be used to diagnose plantar fasciitis and participants will be required to meet a range of selection criteria. Participants will be randomly allocated to one of two treatment arms i ultrasound-guided injection of the plantar fascia with 1 mL of 4 mg mL dexamethasone sodium phosphate experimental group or ii ultrasound-guided injection of the plantar fascia with 1 mL normal saline control group . Blinding will be applied to participants and the investigator performing procedures measuring outcomes and analysing data. Primary outcomes will be pain measured by the Foot Health Status Questionnaire and plantar fascia thickness measured by ultrasound at 4 8 and 12 weeks. All data analyses will be conducted